Efficacy and safety of adding sotagliflozin, a dual sodium-glucose co-transporter (SGLT)1 and SGLT2 inhibitor, to optimized insulin therapy in adults with type 1 diabetes and baseline body mass index ≥ 27 kg/m2
- Danne, T.
- Edelman, S.
- Frias, J.P.
- Ampudia-Blasco, F.J.
- Banks, P.
- Jiang, W.
- Davies, M.J.
- Sawhney, S.
ISSN: 1463-1326, 1462-8902
Argitalpen urtea: 2021
Alea: 23
Zenbakia: 3
Orrialdeak: 854-860
Mota: Artikulua